The global Pharmaceutical Water Market size reach around US$ 50.7 Bn by 2027 and is anticipated to grow at a CAGR of around 9.86% from 2020 to 2027.
Precedence Research, Recently Published Report on “Pharmaceutical Water Market Size, Share, Growth, Trends, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
Crucial factors accountable for market growth are:
- Rising burden of diabetes among the obese and geriatric population
- Rise of biopharmaceutical and generic injectable drugs sectors
- Upsurge in responsiveness for routine checkup and diagnosis
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1179
Water is the one of the foremost commodities utilized by the pharmaceutical sector. Water is extensively employed as vital ingredient, raw material, or solvent in the formulation, processing, and manufacture of active pharmaceutical ingredients, pharmaceutical products, and intermediates, analytical reagents and compendial articles. It might present as an excipient, or employed during synthesis, reconstitution of products, throughout production of finished product, cleaning agent for washing vessels, and primary packing materials among others. There are numerous different grades of water utilized for pharmaceutical purposes. There are numerous particular kinds of packaged waters, differing in their elected applications, packaging limits, and other quality characteristics.
The high demand for steady water supply has forced manufacturers in the pharmaceutical water industry to implement water recycle practices. Water reuse is safeguarding sustainability of water resources and is refining water effectiveness in the value chain. Service providers are providing commission, installation, and validation of purification systems to pharmaceutical customers. Inventions in these systems are fetching prominence in European nations where local manufacturers are firming their global distribution chains.
Growth Factors
Manufacturing of medicines need high-purity water in the manufacture process and the waste water stream can be profoundly laden with contaminants, toxins and organic nutrients which requires to be treated beforehand disposal, necessitating water and waste water treatment equipment. Development of the biopharmaceutical sector can be credited to large unmet medical requirements in the dealing chronic medical circumstances, patent expiry of patented biologic drugs that leads growth of biosimilar drugs, and a great number of clinical pipeline drugs. Furthermore, swift expansion of the vaccines sector is expected to push the biopharmaceutical industry in the near future. Hence, demand for pharmaceutical water is likely to rise, along with the development of the biopharmaceutical and generic injectable sectors throughout the estimate period.
High surge in burden of diabetes amongst the aged and obese populace around the globe is a major influence probable to push the global pharmaceutical water market throughout the prediction period. The pharmaceutical water market in Asia Pacific is expected to advance at a rapid rate throughout the prediction period. Growth of pharmaceutical water and other pharma products to manage with ailments and intensification in responsiveness leading to routine checkup and verdict are the main influences estimated to boost the growth of pharmaceutical water market in Asia Pacific.
Regional Snapshots
The established economies of the U.S., Western Europe and Japan presently signify half of all expenditure in the global water for pharmaceuticals market. These nations are predicted to endure the largest markets for water technologies in this business over coming years.
Europe is the second largest pharmaceutical manufacturing markets and has appeared as a very profitable high value opening to stake holders in the water sector. Some of the principal companies have made noteworthy investments on research and development and also placing themselves as providers of professional solutions for the pharmaceutical industry. These funds are channeled to augment ground-breaking water and wastewater treatment solutions, examine and progress prevailing technologies to address the existing and anticipated fluctuations to the European Pharmacopoeia's water standards.
In Japan, the growth in expenditure on water for pharma is anticipated to be higher, at about 4% annually. The governments is endorsing the augmented application of generic drugs, permitting for prolonged production capacities. In addition, best pricing guarantee restructurings will also go some way to easing the impacts of the patent cliff.
Report Highlights
- The pharmaceutical & biotechnology companies segment captured a substantial cut of the total pharmaceutical water market in 2019
- Growth of biopharmaceutical and generic injectable drugs businesses is probable to push the pharmaceutical water market during impending years
- North America dominated the global pharmaceutical water market in 2019 and predicted to maintain the trend throughout forecast period.
- Companies functioning in the generic injectable market are intensive on the expansion of generic injectable products, particularly generic biologic products such as biosimilars
Key Players & Strategies
Equipment manufacturers are obeying with international pharmacopoeia standards. Leading-edge water purification systems are serving market participants in the pharmaceutical water sector to achieve recognition. Equipment firms are addressing customer specifications and necessities to upsurge the acceptance of systems. Pre-treatment activities are boosting the need for pharmaceutical-grade water purification systems. Region-specific requirements are being furnished by equipment manufacturers on account of diverse degrees of pre-treatment approaches.
Principal companies operating in the pharmaceutical water market comprise B. Braun Melsungen AG, Merck KGaA, Thermo Fisher Scientific, Inc., Baxter International, Inc., Intermountain Life Sciences, Cytiva (Danaher), Standard Reagents, Pvt. Ltd., FUJIFILM Irvine Scientific, CovaChem, LLC, Pfizer, Inc and Fresenius Kabi AG.
Market Segmentation
By Type
- HPLC Grade Water
- Water for Injection
By Application
- Pharmaceutical & Biotechnology Companies
- Academics & Research Laboratories
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pharmaceutical Water Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Pharmaceutical Water Market
5.1. Covid-19: Pharmaceutical Water Industry Impact
5.2. Pharmaceutical Water Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Water Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Water Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Pharmaceutical Water Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
Chapter 7. Global Pharmaceutical Water Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Water Market Revenue by Market Players (2015-2020)
7.1.1.2. Pharmaceutical Water Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Pharmaceutical Water Market, By Product Type
8.1. Pharmaceutical Water Market, by Product Type, 2016-2027
8.1.1. HPLC Grade Water
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Water for Injection
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Pharmaceutical Water Market, By Application
9.1. Pharmaceutical Water Market, by Application, 2016-2027
9.1.1. Pharmaceutical & Biotechnology Companies
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Academics & Research Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Pharmaceutical Water Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type(2016-2027)
10.2.2. Market Revenue Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type(2016-2027)
10.3.2. Market Revenue Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type(2016-2027)
10.4.2. Market Revenue Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type(2016-2027)
10.5.2. Market Revenue Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Baxter International, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Merck KGaA
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. B. Braun Melsungen AG
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Thermo Fisher Scientific, Inc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Cytiva (Danaher)
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Fresenius Kabi AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Pfizer, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. CovaChem, LLC
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Intermountain Life Sciences
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Standard Reagents, Pvt. Ltd
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1179
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
Follow us on LinkedIn| Twitter| Facebook
0 Comments